HomeThemesTypesDBAbout
Showing: ◈ news×◈ medical devices×
Businesses that make sporting goods, children’s toys, jewellery and medical goods have struggled the most with the border costs imposed by the UK’s decision to leave the EU.
The UK left the EU on January 31, 2020, and this began the complex process of de-coupling the UK regulatory regime from that of the EU. This has not been straightforward, particularly where goods move into and out of Northern Ireland (NI), where the EU rules continue to apply, from Great Britain (England, Wales, and Scotland (GB)), where they do not.
We need to forge alliances to continue our global health leadership, writes the director of the Independent Commission on UK-EU Relations.
On 1 August 2023, the UK Government announced an “indefinite” extension to the recognition of CE marking for certain products placed on the market in Great Britain.
In the latest Brexit step-down, many goods will now have indefinite CE mark recognition – but MHRA keeps 2028 and 2030 cut-offs for medical devices.
Adoption of Britain-only rival to EU’s CE designation postponed ‘indefinitely’, say ministers.
The Nuffield Trust think tank has published a new report on the impact of Brexit on the UK’s health and care services. The ongoing monitoring work, funded by the Health Foundation, covers the impact on the NHS and social care workforce, medicine and medical devices supply and the economic cost, and reveals negative effects across these areas.
The impact of Brexit has only added fuel to the fire of severe challenges facing health and social care in the UK, warns the Nuffield Trust.
Sam Bright examines the contribution of Brexit to our current healthcare crisis.
THE SEISMIC CHANGES to the relationship with our nearest neighbours and the impact of Brexit have only added fuel to the fire of severe challenges facing health and social care in the UK today, making people less healthy and widening health inequalities.
Brexit shut off the “relief valve” of immigration from the European Union, worsening workforce shortages in health and social care in the UK, a report from the Nuffield Trust think tank has concluded. / Brexit’s effect has been felt particularly in specialties such as cardiothoracic surgery and anaesthesia, and in dentistry and the care sector.
With the exception of the very lowest risk devices, manufacturers must apply to a UK approved body. Only after they have UKCA certification can their products be placed on the market in England, Wales and Scotland.
Six years after the referendum we can disentangle the evidence and judge the effects on health and care, says Richard Vize.
Following the UK’s exit from the EU, the regulatory landscape for medical devices remains uncertain. Andrew Thompson, PhD, director of therapy research & analysis at GlobalData, explains what companies need to know.
There are a number of measures that the UK Government must take in order to address the challenges of leaving the EU's single market.
There are supply issues with medical devices, fuel and food costs.
UK drug distributors and those involved in the parallel importing of drugs have told the parliamentary Health Select Committee that they want to see the UK remain in the customs union and the single market.
Health Minister Robin Swann has voiced concern about the supply line of medicines to Northern Ireland as a result of a looming Brexit regulatory barrier.
Northern Ireland’s Health Minister Robin Swann has voiced concern about the supply of medicines to the region as a result of a looming Brexit regulatory barrier to securing stock from the rest of the UK.
The chief pharmaceutical officer has warned that without mitigation, the supply of medicines and medical devices into Northern Ireland would be considered a "very high risk area".
The new European Union (EU) Medical Devices Regulation (MDR) and In Vitro Diagnostic Medical Devices Regulation (IVDR) are due to be implemented across the EU from May 2021.
Verdict has conducted a poll to analyse whether medical devices in the UK will continue to have a high degree of safety until all new post-Brexit regulations come into effect by 2023.
Disruption to medical supplies at the UK border in the wake of Brexit will be ‘unavoidable’ warn experts.
SCOTLAND'S two chief medical officers has issued a new warning of shortages to the supply of medicines in the event of a 'no deal' Brexit.